{
  "chapter": "National_Health_Programmes_II_-_NLEP__NTEP___NACO",
  "questions": 
[
  {
    "q_no": 1,
    "question": "Question 1: Identify the organization that has the given emblem:",
    "options": {
      "a": "National Vector Borne Disease Control Programme",
      "b": "National Leprosy Eradication Programme",
      "c": "Integrated Child Development Scheme",
      "d": "National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease, "
    },
    "correct_answer": "b",
    "explanation": "The given image is the emblem of National Leprosy Eradication Programme (NLEP). Characteristics of NLEP emblem: • The lotus in the NLEP emblem symbolizes beauty and purity. • A partially affected thumb, a normal forefinger, and the shape of a house symbolize that leprosy \ncan be cured and a patient with leprosy can be a useful member of the society. • The rising sun symbolizes hope and optimism. • The emblem captures the spirit of hope and positivity in the eradication of leprosy. NLEP is a centrally sponsored health scheme of the Ministry of Health and Family Welfare, Govt. \nof India. Option A: National Vector Borne Disease Control Programme (NVBDCP) Option C: Integrated Child Development Services (ICDS) 372 \nSold by @itachibot Option D: National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular \nDisease, and Stroke (NPCDCS).",
    "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/marrow/psm/National_Health_Programmes_II_-_NLEP__NTEP___NACO_Q1_q.jpg",
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 2,
    "question": "Question 2: The following drug packet is used in: 363 \nSold by @itachibot",
    "options": {
      "a": "TB",
      "b": "Leprosy",
      "c": "Vaginal discharge",
      "d": "Gonorrhea"
    },
    "correct_answer": "b",
    "explanation": "The given image shows the adult blister packet used in the treatment of leprosy.",
    "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/marrow/psm/National_Health_Programmes_II_-_NLEP__NTEP___NACO_Q2_q.jpg",
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 3,
    "question": "Question 3: The Sparsh campaign was launched to spread awareness about which of the following \ndiseases?",
    "options": {
      "a": "HIV",
      "b": "Immunization",
      "c": "Leprosy",
      "d": "TB"
    },
    "correct_answer": "c",
    "explanation": "Sparsh Leprosy Awareness Campaign (SLAC) was introduced in 2017 on the occasion of the \nanti-leprosy day (observed on the last Sunday of January) to promote awareness about various \naspects of leprosy. 373 \nSold by @itachibot Sapna refers to a local school-going girl who will help to spread awareness in the community. The other developments under NLEP are: • Mycobacterium Indicus Prani (MiP) vaccine for multibacillary leprosy patients and their contacts \n(it is in a project mode). • Nikusth: A web-based system for the data management of leprosy cases. Note: Meena is a nine-year-old girl, who is the symbol of UNICEF's Girl Empowerment \nprogramme to impart important messages on gender, child rights, education, health and \ndevelopment in the South Asian region. The posters below depict the role play by Sapna:",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 4,
    "question": "Question 4: A patient with leprosy comes to the PHC following a pinprick to his foot. He noticed it only \nafter seeing bloodstains on the floor and complains of loss of sensation in his foot. After \naddressing the issue, the patient is referred to another centre. Where has he been referred to \nand why?",
    "options": {
      "a": "For secondary prevention to a district hospital.",
      "b": "For tertiary prevention to a district hospital.",
      "c": "For secondary prevention to a district nucleus.",
      "d": "For tertiary prevention to a district nucleus."
    },
    "correct_answer": "d",
    "explanation": "The given clinical scenario of a patient with leprosy having neuropathy needs Micro Cellular \nRubber (MCR) footwear, which is a form of tertiary prevention. He is to be referred to a \ndistrict nucleus which supplies MCR footwear to patients. 374 \nSold by @itachibot",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 5,
    "question": "Question 5: A patient with leprosy, who has completed a course of multi-drug therapy, presents with \ncomplaints of developing painful, tender, and raised lesions on his forehead recently as \nshown in the image below. What is the first-line treatment for him?",
    "options": {
      "a": "Restart multi drug therapy and start thalidomide",
      "b": "Restart multi drug therapy and start prednisolone",
      "c": "Start on clofazimine only",
      "d": "Start on prednisolone only"
    },
    "correct_answer": "d",
    "explanation": "The presence of new erythematous and tender subcutaneous nodules in a patient with leprosy \nindicates that he has developed type II lepra reaction. It is also known as Erythema Nodosum \nLeprosum (ENL) and the first line of treatment is prednisolone. Multi-drug therapy (MDT) should not be restarted in patients who develop lepra reactions after \nthe completion of treatment. Prednisolone is started at a dose of 40 mg per day and gradually tapered by ˜ mg every 2 weeks. \n'Prednisolone card' is given when treatment is started. If the patient becomes steroid-dependent, \nthen clofazimine is added. The key targets of the Global Leprosy Strategy 2021-202è announced by WHO (Accelerating \ntowards a leprosy-free world) are: • 120 countries reporting zero new autochthonous cases. • 70% reduction in the annual number of new cases detected. • ù0% reduction in rate per million population of new cases with Grade 2 disability. • ù0% reduction in rate per million children of new child cases with leprosy. The current goal is the elimination of leprosy.",
    "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/marrow/psm/National_Health_Programmes_II_-_NLEP__NTEP___NACO_Q5_q.jpg",
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 6,
    "question": "Question 6: ABSULS, which is an ASHA-based surveillance project, has been initiated for which of the \nfollowing diseases?",
    "options": {
      "a": "Leishmaniasis",
      "b": "Diarrhoeal diseases",
      "c": "Leprosy",
      "d": "Sexually Transmitted Diseases (STDs)"
    },
    "correct_answer": "c",
    "explanation": "ABSULS which stands for Asha Based Surveillance for Leprosy Suspects has been initiated to \nprioritize leprosy case detection by ASHAs. 375 \nSold by @itachibot",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 7,
    "question": "Question 7: 365 \nSold by @itachibot The treatment of paucibacillary leprosy consists of MDT (which comprises rifampicin, \ndapsone, and clofazimine). The latest recommended regimen is:",
    "options": {
      "a": "2 drug therapy for Ž months",
      "b": "è drug therapy for 12 months",
      "c": "2 drug therapy for 12 months",
      "d": "è drug therapy for Ž months"
    },
    "correct_answer": "d",
    "explanation": "The latest recommendation is è drug therapy for Ž months to treat paucibacillary (PB) leprosy by \nWHO. The regimen consists of rifampicin, dapsone, and clofazimine. Meanwhile, multibacillary (MB) leprosy is treated using the same è drugs for a duration of 12 \nmonths. While the NLEP guidelines earlier mentioned a 2-drug MDT for PB leprosy, the National \nStrategic Plan and Roadmap for Leprosy (202è-2027) now recommends a uniform MDT of è \ndrugs for both PB and MB leprosy. Note: The central government has approved a new treatment regimen for paucibacillary (PB) \nleprosy. The Ministry of Health and Family Welfare has introduced a è-drug regimen for PB \nleprosy instead of a 2-drug regimen. This revised drug regimen will be applicable in India from \nApril 1, 202˜.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 8,
    "question": "Question 8: A District Leprosy Officer is preparing the annual report as per NLEP 2020. Which of the \nfollowing parameters would he not consider as an essential indicator?",
    "options": {
      "a": "Treatment Completion Rate (TCR)",
      "b": "Prevalence rate (PR)",
      "c": "Rate of new cases with Grade II disabilities per 10 lakh population per year",
      "d": "Proportion of new cases correctly diagnosed"
    },
    "correct_answer": "d",
    "explanation": "The proportion of new cases correctly diagnosed is not included under essential indicators. It is a \npart of the quality of service indicators as per NLEP 2020. The essential indicators include: • Annual new case detection rate (ANCDR) per 1 lakh population. • Rate of new cases with grade II disabilities (G2D) per 10 lakh population per year. • Treatment completion rate (TCR) as a proxy to cure rate. • Prevalence rate (PR). Additional epidemiological indicators include: • Proportion of Grade II disabilities among new cases. • Proportion of females among new cases. • Proportion of multibacillary (MB) among new cases. • Proportion of child (0- 14 years) among new cases. • Child rate per 100,000 population. • Scheduled Caste New Case Detection Rate.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 9,
    "question": "Question 9: As per NLEP 2020, which of the following is not a quality of service indicator?",
    "options": {
      "a": "Patient month blister calendar pack stock",
      "b": "Proportion of grade II disabilities among new cases.",
      "c": "Number of relapses reported",
      "d": "Proportion of cases who developed new or additional disability after starting MDT"
    },
    "correct_answer": "b",
    "explanation": "Proportion of grade II disabilities among new cases is not a quality of service indicator. It is an \nadditional epidemiological indicator as per NLEP 2020. The quality of service indicators are: • Patient month blister calendar pack stock. • Absolute number of patients made released from treatment (RFT). 376 \nSold by @itachibot • Number of relapse reported. • Proportion of cases who developed new or additional disability after starting MDT. • Proportion of treatment defaulters. • Proportion of new cases correctly diagnosed.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 10,
    "question": "Question 10: You are part of a rural health camp organized under Project Axshya. Which of the following \ndiseases does it aim to control?",
    "options": {
      "a": "Diabetes",
      "b": "Kala azar",
      "c": "Tuberculosis",
      "d": "Zika Virus disease"
    },
    "correct_answer": "c",
    "explanation": "Project Axshya was launched in 2010 to control TB. Axshya means free from TB which is the \nultimate goal of the project and the National TB Elimination Programme. Project Axshya is being implemented by the International Union Against Tuberculosis and Lung \nDisease (known simply as The Union). The project works to improve access to quality TB care and \ncontrol through a partnership between the government and civil society. The guiding principles of project Axshya are: • Universal access to quality TB services • Community participation in TB care and control • Sustainable interventions and equitable distribution of project benefits with social and gender \nsensitivity",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 11,
    "question": "Question 11: You are working as a medical officer in a PHC where you diagnose a patient with TB. Within \nhow many days do you have to report it to the District Health Officer?",
    "options": {
      "a": "7 days",
      "b": "1˜ days",
      "c": "è0 days",
      "d": "21 days"
    },
    "correct_answer": "c",
    "explanation": "The guidelines for TB notification under the RNTCP is within è0 days (a month) of receiving a \nnew case. The notification must be done to the District Health Officer or the Chief Medical Officer \nof a District Hospital by the practitioner who diagnosed it. Note: RNTCP has now been renamed to National Tuberculosis Elimination Program (NTEP).",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 12,
    "question": "Question 12: Which of the following is true about the Revised National Tuberculosis Control Programme?",
    "options": {
      "a": "Follow-up sputum smear examination at the end of intensive phase only",
      "b": "Directly Observed Treatment Short course strategy is applied",
      "c": "Treatment is only given to smear positive cases",
      "d": "MDR TB is resistance to either rifampicin or isoniazid"
    },
    "correct_answer": "b",
    "explanation": "DOTS stands for Directly Observed Treatment Short-course and is given by peripheral and \nvoluntary health workers. Recent updates in RNTCP: • Active case finding for TB has been started. • Follow up: • On treatment: monthly follow up. • After treatment: Follow up at Ž, 12, 1š and 24 months. • A sputum smear examination must be done at the end of intensive phase (IP) and at the end of \ntreatment. 377 \nSold by @itachibot",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 13,
    "question": "Question 13: A patient presents with fever, productive cough, and weight loss. He gives a history of not \nhaving completed treatment for tuberculosis thrice in the past. Extensively drug-resistant TB \nis suspected. How is this entity defined?",
    "options": {
      "a": "Resistance to INH + Amikacin + Ofloxacin + Ethambutol",
      "b": "Resistance to INH + Rifampicin + Amikacin",
      "c": "Resistance to Rifampicin + Amikacin+ Ofloxacin",
      "d": "Resistance to INH + Rifampicin + Ofloxacin + Linezolid"
    },
    "correct_answer": "d",
    "explanation": "™DR-TB (extensively drug-resistant TB) is defined as multi-drug resistant TB (resistant to \nrifampicin and isoniazid) which is also resistant to one fluoroquinolone (eg. ofloxacin) \nAND resistant to atleast one additional group A drug (as of 2021, these \nare bedaquiline and linezolid) It is usually seen in patients who have previously received treatment for TB and have either failed \nto complete treatment or relapsed.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 14,
    "question": "Question 14: A patient on HAART presents with complaints of fever and expectorant cough for two weeks. \nWhat is the investigation to be ordered first?",
    "options": {
      "a": "Sputum microscopy",
      "b": "Interferon Gamma Release Assay",
      "c": "CB- NAAT",
      "d": "Sputum microscopy and Chest ™-ray"
    },
    "correct_answer": "c",
    "explanation": "An HIV patient suspected to have TB is directly investigated by CB-NAAT (Cartridge Based \nNucleic Acid Amplification Test). TB is a very serious infection in the immunocompromised and can lead to its most severe form as \nmiliary TB and cause death. Since TB in HIV does not have its typical presentation, early \nsuspicion and advanced diagnosis is the key to preventing mortality. Diagnostic algorithm for TB:",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 15,
    "question": "Question 15: Which of the following statements is false under the National Tuberculosis Elimination \nProgramme?",
    "options": {
      "a": "Continuation phase for new sputum smear positive: HRE for 1Ž weeks",
      "b": "Intensive phase for sputum smear positive after loss to follow up: HRZE for š weeks",
      "c": "Continuation phase for sputum smear positive recurrent case: HRE for 1Ž weeks",
      "d": "Intensive phase for sputum smear positive after failure to treatment: HRZES for 12 weeks"
    },
    "correct_answer": "d",
    "explanation": "Under National Tuberculosis Elimination Programme (NTEP) guidelines Initiation phase (IP) for \nboth new and previously treated cases which are H and R sensitive is HRZE for š weeks. 378 \nSold by @itachibot",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 16,
    "question": "Question 16: Which of the following is the most peripheral centre under the Revised National Tuberculosis \nControl Programme organization structure?",
    "options": {
      "a": "District TB centre",
      "b": "Intermediate Reference Laboratory",
      "c": "Tuberculosis Unit",
      "d": "Designated Microscopy Centre"
    },
    "correct_answer": "d",
    "explanation": "Among the options given, Designated Microscopy Centre is the most peripheral centre.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 17,
    "question": "Question 17: Which is the new online software launched under the national tuberculosis elimination \nprogram (NTEP) by the government to monitor TB patients?",
    "options": {
      "a": "NIKSHAY",
      "b": "NISCHAY",
      "c": "E-DOTS",
      "d": "NIKUSTH"
    },
    "correct_answer": "a",
    "explanation": "Nikshay is the new online software launched under the national tuberculosis elimination program \nfor monitoring TB patients. Nikusth is the new online software for monitoring leprosy patients. Nischay is a pregnancy test kit.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 18,
    "question": "Question 18: Choose the false statement regarding the initiatives and strategies for tuberculosis.",
    "options": {
      "a": "The Stop TB strategy was announced by the World Health Organisation",
      "b": "The STOP TB strategy has a target of ending TB by achieving an incidence rate of &lt;10 people ",
      "c": "The \"Practical approach to lung health\" was launched by the WHO for syndromic managment ",
      "d": "The End TB strategy is a 20 year programme"
    },
    "correct_answer": "b",
    "explanation": "The Stop TB strategy was announced by World Health Organisation to reduce the global burden \nof TB by 201˜ (and not ending TB). The End TB strategy is a 20-year programme with tagline “A world free of TB - Zero TB deaths, \nZero TB disease, and Zero TB suffering”. It aims to: • end TB by achieving an incidence rate of &lt;10 people/1 lakh population per year by 20è˜. • reduce TB deaths by ù˜% and cut new cases by ù0% by 20è˜. The \"Practical approach to lung health initiative\" was launched by the WHO as a syndromic \napproach to the management of patients who attend primary health care services for respiratory \nsymptoms. Ending the TB epidemic is also one of the targets of the Sustainable Development Goals (SDG) \nspecifically under Goal è (to “ensure healthy lives and promote well-being for all at all ages”). 379 \nSold by @itachibot WHO defines that \"Tuberculosis control\" would be achieved when the prevalence of the natural \norder of infection in the age group of 0-14 years is of the order of 1% (40% in India currently). Vision of End TB: A world fre \ne of TB- zero deaths, disease \nand suffering due to TB Goal: End the global TB epid \nemic Indicators \nTargets SDG 20è0 \nEnd TB 20è˜ Reduction in no. of TB death \ns compared with 201˜ ù0% \nù˜% Reduction in TB incidence ra \nte compared with 201˜ ù0%(<10/1,00,0 \n00) š0%(<20/1,00,0 \n00) 0% \n0% TB-affected families facing ca \ntastrophic costs due to TB",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 19,
    "question": "Question 19: Which of the following group of individuals would you not target under the programme \nrepresented by the logo shown below?",
    "options": {
      "a": "Sex workers",
      "b": "Migrants",
      "c": "Transgenders",
      "d": "Industrial workers"
    },
    "correct_answer": "d",
    "explanation": "The red ribbon shown is a part of the logo of the National AIDS Control Organization (NACO) \nprogramme. Industrial workers are not included in the target population under NACO. Target interventions for the control of AIDS transmission are done for: • High-risk groups like sex workers • Men who have sex with men • Transgender • Injecting drug users • Bridge population like migrants and long-distance truckers The services offered through targeted interventions include detection and treatment for sexually \ntransmitted diseases and condom distribution. The logo of NACO: 380 \nSold by @itachibot",
    "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/marrow/psm/National_Health_Programmes_II_-_NLEP__NTEP___NACO_Q19_q.jpg",
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 20,
    "question": "Question 20: Which of the following statements is false regarding the target interventions under National \nAIDS Control Organisation?",
    "options": {
      "a": "Lubricants are given to homosexual men",
      "b": "Clean needles and syringes are given to injecting drug users",
      "c": "Condoms are not given to bridge population",
      "d": "Opioid substitution therapy is given to Injecting Drug Users"
    },
    "correct_answer": "c",
    "explanation": "Bridge populations are supplied with condoms under the NACO target interventions. Target interventions: General: • Detection and treatment for sexually transmitted diseases • Condom distribution For injecting drug users: • Distribution of clean needles and syringes. • Abscess prevention and management. • Opioid substitution therapy. • Linkage with detoxification and rehabilitation services. For homosexual men and transgenders: • Provision of lubricants. • Provision of project-based clinics for sexually transmitted infections.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 21,
    "question": "Question 21: A physician follows the two test protocol for the diagnosis of HIV in a patient. It consists of:",
    "options": {
      "a": "Western blot as the first test",
      "b": "Line immunoassay as the second test",
      "c": "HIV ELISA as the second test",
      "d": "Western blot as the second test"
    },
    "correct_answer": "c",
    "explanation": "The two test protocol for the diagnosis of HIV consists of ELISA as the second test. If the initial \nELISA is positive, a second ELISA is carried out. If the second ELISA is also positive, only then \nthe case is reported to be positive. Investigations involved in HIV testing strategies: 381 \nSold by @itachibot • ELISA/ rapid tests. • Confirmatory tests with high specificity like western blot and line immunoassays are used in \nproblem cases eg: indeterminate/ discordant cases of rapid tests. In India, NACO provides western blot (WB) confirmatory testing only to resolve indeterminate \nresults on previous serological testing. It is not used for routine confirmation after a positive \nresult on screening tests. Drawbacks of WB include low rates of detection during acute \nHIV infection and misclassification of HIV-2 infection. Note: The western blot is used as a confirmatory test after 2 indeterminate primary tests (ELISA). \nIt is essentially the third test used and does not fit into the two test protocol.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 22,
    "question": "Question 22: As a medical officer involved in the sentinel surveillance for HIV under the National AIDS \nControl Programme, your duties include all of the following except:",
    "options": {
      "a": "Estimation of total infection in the community",
      "b": "Estimation of total cases in hospitals",
      "c": "Estimation of trend of disease",
      "d": "Classification of districts"
    },
    "correct_answer": "b",
    "explanation": "As a medical officer involved in the sentinel surveillance, the estimation of total cases in hospitals \nis not included in the sentinel surveillance for HIV under National AIDS Control Programme \n(NACO). The aims of the HIV sentinel surveillance include: • Determine the level of HIV infection in the community. • Understand the trends of HIV epidemic. • Understand the geographical spread of HIV infection and classify districts according to \nepidemiological and vulnerability criteria. These objectives are achieved by conducting annual cross-sectional surveys of the risk group in \nthe same geographical place.",
    "image": null,
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 23,
    "question": "Question 23: Which of the following is targetted by the establishment bearing the logo shown below:",
    "options": {
      "a": "Family planning",
      "b": "Immunisation",
      "c": "Sexually Transmitted Diseases",
      "d": "Maternal and Child Health Services"
    },
    "correct_answer": "c",
    "explanation": "The logo shown represents Suraksha Clinics which are established for the management of sexually \ntransmitted diseases (STDs) where patients are given color-coded kits.",
    "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/marrow/psm/National_Health_Programmes_II_-_NLEP__NTEP___NACO_Q23_q.jpg",
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  },
  {
    "q_no": 24,
    "question": "Question 24: Choose the wrong combination of the colour-coded STI kits among the given options.",
    "options": {
      "a": "OPV booster, DPT booster and Vitamin A",
      "b": "OPV Booster, DPT booster, MR, JE and Vitamin A",
      "c": "OPV booster, DPT booster, JE vaccine and Vitamin A",
      "d": "OPV Booster, DPT booster, MR and Vitamin A"
    },
    "correct_answer": "c",
    "explanation": "Kit 4 is blue in colour and is used for genital ulcers. These kits are given at Suraksha clinics. 382 \nSold by @itachibot National Health Programmes III - NIS, JSY, RBSK and Others",
    "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/marrow/psm/National_Health_Programmes_II_-_NLEP__NTEP___NACO_Q24_q.jpg",
    "explanation_image": null,
    "chapter_heading": "National Health Programmes II - NLEP  NTEP   NACO"
  }
]}
